LMB – Updated view following quarter financial report. Ahead of the earnings report for Limbach Holdings’ fourth quarter ending December 2024, the average of the two contributions to the consensus was $0.77 in earnings per share on $149.37 million in… NX – Revised outlook on quarter earnings results. Last week Quanex Building Products reported an […]
Category: SIGA
Weekly Comments – July 29, 2024 – BXC, HVT, LXFR, MPX, PTSI, SIGA, ULH
BXC – Preview of quarter earnings report. BlueLinx Holdings is scheduled to release financial results for the second quarter ending June 2024, on Tuesday this week after the market close. A conference call to go over the details with analysts and… HVT – View in advance of financial release. This week Wednesday after the market […]
New Coverage – SIGA Technologies, Inc. (SIGA)
SIGA Technologies is focused on an antiviral drug for treatment of the variola virus that causes human smallpox. A highly infectious disease, small pox has been all but completely irradicated through the widespread use of a vaccine. Only recently have drug developers attempted to bring an antiviral drug to the market. In 1918, the FDA […]
Trading Guides-Estimates
Trading Guides and Estimates have been updated as of May 12, 2025. You need to be logged in to view the rest of the content. Please Log In. Not a Member? Join Us